1265723

Janssen Biotech, Inc. — FEI 3001610451

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 10, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Malvern, PA (United States)